Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Sanara MedTech Inc. (WNDM) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 8-K Regulation FD Disclosure  Interactive Data
08/14/2023 8-K Investor presentation, Quarterly results
Docs: "SANARA MEDTECH INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS June 30, December 31, 2023 2022 Assets Current assets Cash $ 6,060,228 $ 8,958,995 Accounts receivable, net 7,141,105 6,805,761 Accounts receivable – related party 20,662 98,548 Royalty receivable 49,344 99,594 Inventory, net 4,420,864 3,549,000 Prepaid and other assets 485,734 1,104,611 Total current assets 18,177,937 20,616,509 Long-term assets Property and equipment, net 1,240,269 1,416,436 Right of use assets – operating leases 2,030,938 806,402 Goodwill 3,601,781 3,601,781 Intangible assets, net 30,143,578 31,509,980 Investment in equity securities 3,084,278 3,084,278 Total long-term assets 40,100,844 40,418,877 Total assets $ 58,278,781 $ 61,035,386 Liabilities and shareholders’ equity Current liabilities Accounts payab..."
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/11/2023 D Form D - Notice of Exempt Offering of Securities:
08/02/2023 8-K Quarterly results
06/06/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/05/2023 4 TANZBERGER ERIC D (Director) has filed a Form 4 on Sanara MedTech Inc.
Txns: Granted 2,936 shares @ $0
06/05/2023 4 STUCKERT JAMES W (10% Owner) has filed a Form 4 on Sanara MedTech Inc.
Txns: Granted 2,802 shares @ $0
06/05/2023 4 DeSutter Robert Andrew (Director) has filed a Form 4 on Sanara MedTech Inc.
Txns: Granted 2,936 shares @ $0
06/05/2023 4 Ortwein Sara N (Director) has filed a Form 4 on Sanara MedTech Inc.
Txns: Granted 2,802 shares @ $0
06/05/2023 4 Major Eric D (Director) has filed a Form 4 on Sanara MedTech Inc.
Txns: Granted 2,669 shares @ $0
06/05/2023 4 Nixon Ronald T (10% Owner) has filed a Form 4 on Sanara MedTech Inc.
Txns: Granted 9,609 shares @ $0
Granted 8,808 shares @ $0
06/05/2023 4 Salamone Ann Beal (Director) has filed a Form 4 on Sanara MedTech Inc.
Txns: Granted 2,402 shares @ $0
06/05/2023 4 Mack Roszell III (Director) has filed a Form 4 on Sanara MedTech Inc.
Txns: Granted 2,802 shares @ $0
06/05/2023 3 Major Eric D (Director) has filed a Form 3 on Sanara MedTech Inc.
04/21/2023 ARS Form ARS - Annual Report to Security Holders:
04/21/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/21/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/21/2023 4 Fleming Zachary B. (CEO) has filed a Form 4 on Sanara MedTech Inc.
Txns: Paid exercise price by delivering 1,101 shares @ $40.5, valued at $44.6k
Paid exercise price by delivering 812 shares @ $40.5, valued at $32.9k
Paid exercise price by delivering 325 shares @ $43.3, valued at $14.1k
Paid exercise price by delivering 717 shares @ $41.5, valued at $29.8k
03/21/2023 4 McMahon Rebecca E (President - R&D) has filed a Form 4 on Sanara MedTech Inc.
Txns: Paid exercise price by delivering 201 shares @ $41.5, valued at $8.3k
03/21/2023 4 McNeil Michael D. (CFO) has filed a Form 4 on Sanara MedTech Inc.
Txns: Paid exercise price by delivering 658 shares @ $40.5, valued at $26.6k
Paid exercise price by delivering 253 shares @ $43.3, valued at $11k
Paid exercise price by delivering 532 shares @ $41.5, valued at $22.1k
03/20/2023 8-K Quarterly results
03/20/2023 10-K Annual Report for the period ended December 31, 2022
03/06/2023 4 McMahon Rebecca E (President - R&D) has filed a Form 4 on Sanara MedTech Inc.
Txns: Granted 2,410 shares @ $0
03/06/2023 4 McNeil Michael D. (CFO) has filed a Form 4 on Sanara MedTech Inc.
Txns: Granted 4,217 shares @ $0
03/06/2023 4 Fleming Zachary B. (CEO) has filed a Form 4 on Sanara MedTech Inc.
Txns: Granted 6,988 shares @ $0
Granted 1,736 shares @ $0
02/24/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Sales Agreement",
"Fort Worth, TX 76102",
"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 , and the Prospectus Supplement constituting a part of this Registration Statement of our report dated March 30, 2022, relating to the consolidated financial statements of Sanara MedTech Inc. and its subsidiaries appearing in the entity’ s Annual Report on Form 10-K for the year ended December 31, 2021. We also consent to the reference to us under the caption “Experts” in the Prospectus Supplement."
02/24/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
02/22/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact:"
12/16/2022 8-K Quarterly results
12/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy